Test whether FGF19 helps non-diabetic kidney disease
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at FGF19 to see if it can improve chronic kidney disease in people who do not have diabetes. Participants may receive FGF19 (and may need extra testing such as muscle biopsies).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic kidney disease with an eGFR under 60, or you have been on dialysis for more than 3 months
- You have not had a kidney transplant before
- Your body mass index (BMI) is between 18 and 30
- If you can become pregnant, you must use effective birth control
- You do not have diabetes (based on recent blood sugar and diabetes medicines)
- You can give informed consent and agree to study procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two experimental treatments—one that reduces protein in urine and another that may help control blood sugar and weight—for people with chronic kidney disease. It aims to find safer, more effective ways to slow kidney damage.
This trial tests whether taking dapagliflozin (a drug often used for diabetes and heart health) can help improve kidney structure and blood flow in people who received a kidney transplant at least 9 months ago. It may benefit those whose kidney function is stable, regardless of whether they have diabetes.
This study follows adults with chronic kidney disease who are not on dialysis. It aims to better understand kidney health and test what care or monitoring might help over time.
This study tests two new methods to measure how well your kidneys can handle extra work, called kidney reserve. It might help find early signs of kidney problems in people with sickle cell disease or those who have donated a kidney.
This study looks at how a protein called FGF23, which helps control minerals in your body, changes as kidney disease progresses. By understanding this, doctors may find better ways to manage kidney disease.
This study looks at a blood hormone called FGF23 and whether it is linked to heart (cardiovascular) problems in people with anemia. It also compares people with anemia who do and do not have chronic kidney disease, which may help researchers understand risk and targets.
Hear when a new Chronic Kidney Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.